Boris Birmaher mostly deals with Psychiatry, Depression, Clinical psychology, Major depressive disorder and Bipolar disorder. His Psychiatry research integrates issues from Internal medicine and Randomized controlled trial. The Cognitive therapy research Boris Birmaher does as part of his general Depression study is frequently linked to other disciplines of science, such as Clinical Global Impression, therefore creating a link between diverse domains of science.
His studies in Cognitive therapy integrate themes in fields like Supportive psychotherapy and Cognitive behavioral therapy. Boris Birmaher interconnects Psychosocial, Epidemiology and Mood disorders in the investigation of issues within Clinical psychology. His Major depressive disorder study also includes
His primary areas of study are Psychiatry, Clinical psychology, Bipolar disorder, Depression and Anxiety. His Psychiatry study deals with Randomized controlled trial intersecting with Clinical trial. His Clinical psychology study incorporates themes from Cognitive behavioral therapy, Cognitive therapy, Schedule for Affective Disorders and Schizophrenia and Family history.
The study incorporates disciplines such as Psychosocial, Psychopathology, Neuroimaging and Pediatrics in addition to Bipolar disorder. The various areas that Boris Birmaher examines in his Depression study include Internal medicine, Risk factor and Fluoxetine. As part of his studies on Anxiety, Boris Birmaher often connects relevant areas like Sertraline.
Boris Birmaher mainly focuses on Bipolar disorder, Clinical psychology, Psychiatry, Anxiety and Mood. In his work, Functional magnetic resonance imaging is strongly intertwined with Psychopathology, which is a subfield of Bipolar disorder. His work deals with themes such as Psychological intervention, Rating scale, Social anxiety, Randomized controlled trial and Spectrum disorder, which intersect with Clinical psychology.
Boris Birmaher integrates several fields in his works, including Psychiatry and Injury prevention. His studies deal with areas such as Pill and Sertraline as well as Anxiety. His research in Mood intersects with topics in Not Otherwise Specified, Mood disorders and Family history.
Psychiatry, Bipolar disorder, Clinical psychology, Anxiety and Mood are his primary areas of study. Psychiatry connects with themes related to Functional magnetic resonance imaging in his study. His research integrates issues of Psychosocial, Psychopathology, Mood disorders and Comorbidity in his study of Bipolar disorder.
His Clinical psychology research is multidisciplinary, relying on both Anxiety disorder, Separation anxiety disorder and Randomized controlled trial. In his study, Pill is inextricably linked to Sertraline, which falls within the broad field of Anxiety. His Mood research includes themes of Cognitive skill, Confounding and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Childhood and adolescent depression: a review of the past 10 years. Part I.
Boris Birmaher;Neal D. Ryan;Douglas E. Williamson;David A. Brent.
Journal of the American Academy of Child and Adolescent Psychiatry (1996)
Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety
John T. Walkup;Anne Marie Albano;John Piacentini;Boris Birmaher.
The New England Journal of Medicine (2008)
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials
Jeffrey A. Bridge;Satish Iyengar;Cheryl B. Salary;Rémy P. Barbe.
JAMA (2007)
Developmental traumatology part I: biological stress systems
Michael D De Bellis;Andrew S Baum;Boris Birmaher;Matcheri S Keshavan.
Biological Psychiatry (1999)
A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.
David A. Brent;Diane Holder;David Kolko;Boris Birmaher.
Archives of General Psychiatry (1997)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Lakshmi N. Yatham;Sidney H. Kennedy;Sagar V. Parikh;Ayal Schaffer.
Bipolar Disorders (2013)
Oppositional defiant disorder and conduct disorder: a review of the past 10 years, part II.
Jeffrey D. Burke;Rolf Loeber;Boris Birmaher.
Journal of the American Academy of Child and Adolescent Psychiatry (2002)
Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
Martin B. Keller;Neal D. Ryan;Michael Strober;Rachel G. Klein.
Journal of the American Academy of Child and Adolescent Psychiatry (2001)
Clinical Course of Children and Adolescents With Bipolar Spectrum Disorders
Boris Birmaher;David Axelson;Michael Strober;Mary Kay Gill.
Archives of General Psychiatry (2006)
Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controlled Trial
David Brent;Graham Emslie;Greg Clarke;Karen Dineen Wagner.
JAMA (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The Ohio State University
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
University of Toronto
Brown University
University of California, Berkeley
University of California, Los Angeles
University of Pittsburgh
University of Pittsburgh
University of British Columbia
Arizona State University
University of Pennsylvania
University of Freiburg
Novartis (Switzerland)
National Institute of Chemical Physics and Biophysics
Public Health England
Örebro University
Defence Science and Technology Laboratory
Technical University of Denmark
Goddard Space Flight Center
Xidian University
Virginia Tech
New York University
Northwestern University
Yale University